News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Smith & Nephew plc (SNN) Continues to Deliver Against its Strategic Priorities


3/8/2010 10:46:25 AM

LONDON, March 8 /PRNewswire-FirstCall/ -- Smith & Nephew plc , the global medical technology business, continues to deliver on its strategic priorities by introducing new and innovative products from its Orthopedics and Endoscopy business units at this year's American Academy of Orthopaedic Surgeons ("AAOS") Annual Meeting. Smith & Nephew's presence at this year's Annual Meeting will feature the launch of several new products, as well as advances in Smith & Nephew's current portfolio, and representatives from Smith & Nephew Orthopaedic's medical education platform, KLEOS, will be on hand. The combined success of Smith & Nephew's Orthopaedics, Endoscopy, Advanced Wound Management and Biologics & Clinical Therapies businesses reflects Smith & Nephew's continued focus on providing its customers with innovative technologies, comprehensive medical education and superior customer service.

Management in attendance at this year's meeting will include Dave Illingworth; Joe DeVivo, President Orthopaedics; Mike Frazzette, President Endoscopy; Mark Augusti, President Biologics & Clinical Therapies; and Tom Dugan, President North American Business, Advanced Wound Management."

For more information on surgeon presentations and product demonstrations, please visit Orthopaedics, Wound Management and Biologics at booth 1629 and Endoscopy at booth 1643.

About Us

Smith & Nephew is a global medical technology business, specialising in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.

Forward-Looking Statements

This press release contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regarding expected revenue growth and trading margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation, claims and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.

Trademark of Smith & Nephew. Certain marks registered US Patent and Trademark Office.

CONTACT: Investors: Liz Hewitt or Phil Cowdy, both of Smith & Nephew,
+44(0)20-7401-7646; or Press: Katie Cralle of Brunswick Group,
+1-212-333-3810

Web site: http://www.smith-nephew.com/


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES